Analysts’ Viewpoint
Usage of vascular grafts is rising at a rapid pace owing to an increase in incidence of health conditions such as chronic kidney and cardiovascular diseases.
Rise in the number of lifestyle-related disorders, surge in the geriatric population, increase in health care expenditure, and improvement in healthcare infrastructure are driving the demand for vascular graft surgeries or procedures.
Government and regulatory bodies of various countries are adopting cost-containment measures to reduce the health care burden, especially in developed economies. This shift from volume- to value-based system is driven by various measures taken by governments, health care providers, insurance payers, and life sciences companies.
Leading vascular graft companies, including Terumo Corporation and Vascular Graft Solutions, play a crucial role in the development of these grafts.
Vascular surgery involves rerouting blocked or narrowed artery in order to restore the blood flow to a specific organ (heart, brain, leg, etc.). Surgeons use a synthetic or natural graft to connect to a healthy artery to the narrowed artery beyond the blocked point in order to create another path for the blood flow. Different types of vascular bypass graft surgeries can be performed depending on the location of the blockage.
Vascular bypass graft surgery is an inpatient procedure performed by a cardiothoracic surgeon, neurosurgeon, or vascular surgeon in hospital setting. Bypass surgeries are mostly scheduled in advance. For each bypass surgery, a graft must be chosen to create a new route around the blocked section of the artery.
The graft could be taken from a vein or artery, or it can be synthetic. Objective vascular bypass surgery is performed to bypass the blocked or narrow artery and restore the blood flow. The most common bypass surgeries are coronary artery bypass grafting/surgery, cerebral artery bypass surgery, renal artery bypass surgery, aortoiliac or aortofemoral bypass surgery, and peripheral bypass surgery.
Chronic kidney disease (CKD), also known as chronic kidney failure, is one of the major risk factors for diabetes, hypertension, cardiovascular diseases, and others diseases. It involves a gradual loss of the kidney function. Advanced chronic kidney disease can lead to dangerous levels of fluids, electrolytes, and waste build up in the body.
According to the National Institute of Diabetes & Digestive & Kidney Diseases, more than 37 million adults in the U.S. have CKD. According to the Centers for Disease Control and Prevention, diabetes and high blood pressure are the leading causes of kidney failure in the country, accounting for three out of four new cases.
Consumption of alcohol & tobacco and hereditary factors increase the number of cardiovascular disorders. According to the WHO, cardiovascular diseases (CVDs) accounted for an estimated 17.9 million deaths in 2019, representing 32% of all global deaths. Of these, around 85% were due to heart attack and stroke. Moreover, rise in the number of cancer cases increases the demand for central venous catheters and implantable ports & grafts for the administration of chemotherapy medications and blood transfusion.
Incidence of lifestyle-related disorders such as diabetes, blood pressure, and obesity has increased due to unhealthy lifestyle & diet and lack of exercise. According to the International Diabetes Federation (IDF), around 527 million adults across the world were living with diabetes in 2021, and the number is expected to rise to 643 million by 2030 and 783 million by 2045. Hypertension, or elevated blood pressure, is another disorder caused by unhealthy diet or excessive salt consumption, physical inactivity, or overweight/obesity.
According to the WHO, globally, an estimated 1.28 billion adults aged 30 years to 79 years have hypertension, especially people living in low and middle income countries. Hence, increase in the incidence of lifestyle-related disorders among the global population propels the need for hospitalization, which in turn augments the global demand.
In terms of product, the global vascular grafts market has been classified into endovascular stent graft, peripheral vascular graft, hemodialysis access graft, bypass graft, and others. The endovascular stent grafts segment dominated the global industry in terms of share in 2021. This stent graft usually supports the weak areas of the aorta. It is a non-invasive surgical procedure used to treat abdominal aortic aneurysm.
Based on source, the global vascular grafts market has been segregated into biological, synthetic, and biosynthetic. The synthetic segment accounted for major share in 2021. Synthetic vascular grafts are non-toxic, non-allergenic grafts made of materials such as Teflon, glass, or lead. These have the ability to re-adjust the wall configuration to form a good mechanical fit, while making an opening in blood vessels or diverging them.
In terms of size of vascular graft, the global vascular grafts business has been bifurcated into large size vascular grafts and small size vascular grafts. Large size vascular grafts accounted for major share of the market demand in 2021. Advantages such as wide availability, high patency rate, and constant flow of blood are driving the large size vascular grafts segment.
Based on application, the global vascular grafts market has been divided into coronary artery bypass, aneurysm, vascular occlusion, renal failure, critical limb ischemia, and others.
The coronary artery bypass segment held a dominant share in 2021 due to increase in the incidence of cardiovascular diseases and rise in demand for treatment procedures. According to the WHO, about 17.9 million people succumb to cardiovascular diseases every year, which is 32% of total global deaths.
In terms of end-user, the market segmentation comprises hospitals, ambulatory surgical centers, cardiac catheterization laboratories, specialty clinics, and others. The hospitals segment held the largest market share in 2021. Hospitals are the most preferred choice and highly favorable settings for procedures requiring vascular access, ranging from cardiovascular to dialysis. Therefore, the segment is expected to grow at a rapid pace during the forecast period.
North America accounted for major share of the global vascular grafts market in 2021. The U.S. dominated the region due to large patient pool, high prevalence of heart diseases, advancements in clinical trials for various vascular disorders & diseases, and surge in demand among vascular surgeons for the development of new products. According to the Centers for Disease Control and Prevention, about 697,000 people in the U.S. succumbed to heart disease in 2020 i.e., 1 in every 5 deaths; one person dies every 34 seconds in the country from cardiovascular disease.
Asia Pacific is expected to be the fastest growing region during the forecast period. According to the America College of Cardiology, in 2019, CVD accounted for 9.6 million deaths among men and 8.9 million deaths among women. Furthermore, over 6 million of these deaths occurred in people aged between 30 and 70. The highest number of CVD deaths occurred in China, followed by India, Russia and Indonesia. Moreover, demand for vascular graft modification among surgeons is increasing owing to rise in the number of awareness programs by vascular associations across Asia Pacific. Surge in the incidence of coronary artery disease is likely to drive market expansion in the region.
The global industry is consolidated, with the presence of a small number of large companies. Majority of these players are investing significantly in research & development to develop advanced vascular grafts.
Expansion of product portfolio and mergers & acquisitions are prominent strategies adopted by key players. Prominent players in the industry are B. Braun SE, Becton, Dickinson and Company, Cook Medical, Inc., CryoLife, Inc., Getinge AB, Heart Medical, Junken Medical Co., Ltd., LeMaitre Vascular, Inc., Medtronic, Vascular Graft Solutions, and W. L. Gore & Associates, Inc.
Leading players in the industry have been profiled in the report based on parameters such as company overview, financial standing, strategies, portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 2.0 Bn |
|
Forecast Value in 2031 |
US$ 3.7 Bn |
|
Growth Rate (CAGR) |
5.6% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global market was valued at US$ 2.0 Bn in 2021
It is projected to reach a value of more than US$ 3.7 Bn by 2031
The CAGR contracted at 1.7% from 2017 to 2021
The market is anticipated to grow at a CAGR of 5.6% from 2022 to 2031
Increase in the incidence of target diseases and rise in the number of lifestyle-related disorders.
North America is expected to account for the largest share.
Braun SE, BD, Cook Medical, Inc., CryoLife, Inc., Getinge AB, Heart Medical, Junken Medical Co., Ltd., LeMaitre Vascular, Inc., Medtronic, Vascular Graft Solutions, and W. L. Gore & Associates, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vascular Grafts Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vascular Grafts Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pipeline Analysis
5.2. Global Prevalence of Chronic Kidney Diseases
5.3. Global Prevalence of Cardiovascular Diseases
5.4. Covid-19 Pandemic Impact on the Industry
6. Global Vascular Grafts Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Endovascular Stent Graft
6.3.2. Peripheral Vascular Graft
6.3.3. Hemodialysis Access Graft
6.3.4. Bypass Graft
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Vascular Grafts Market Analysis and Forecast, by Size of Vascular Graft
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
7.3.1. Large Size Vascular Graft
7.3.2. Small Size Vascular Graft
7.4. Market Attractiveness Analysis, by Size of Vascular Graft
8. Global Vascular Grafts Market Analysis and Forecast, by Source
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Source, 2017–2031
8.3.1. Synthetic
8.3.1.1. Polytetrafluethylene (PTFE)
8.3.1.2. Polyurethane (PU)
8.3.1.3. Dacron
8.3.1.4. Others
8.3.2. Biological
8.3.2.1. Bovine Vein
8.3.2.2. Saphenous Vein
8.3.2.3. Others
8.3.3. Biosynthetic
8.3.3.1. Ovine Collagen with Polyester
8.3.3.2. Others
8.4. Market Attractiveness Analysis, by Source
9. Global Vascular Grafts Market Analysis and Forecast, by Application
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Coronary Artery Bypass
9.3.2. Aneurysm
9.3.3. Vascular Occlusion
9.3.4. Critical Limb Ischemia
9.3.5. Renal Failure
9.3.6. Others
9.4. Market Attractiveness Analysis, by Application
10. Global Vascular Grafts Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgery Centers
10.3.3. Cardiac Catheterization Laboratories
10.3.4. Specialty Clinics
10.3.5. Others
10.4. Market Attractiveness Analysis, by End-user
11. Global Vascular Grafts Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Vascular Grafts Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Endovascular Stent Graft
12.2.2. Peripheral Vascular Graft
12.2.3. Hemodialysis Access Graft
12.2.4. Bypass Graft
12.2.5. Others
12.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
12.3.1. Large Size Vascular Graft
12.3.2. Small Size Vascular Graft
12.4. Market Value Forecast, by Source, 2017–2031
12.4.1. Synthetic
12.4.1.1. Polytetrafluethylene (PTFE)
12.4.1.2. Polyurethane (PU)
12.4.1.3. Dacron
12.4.1.4. Others
12.4.2. Biological
12.4.2.1. Bovine Vein
12.4.2.2. Saphenous Vein
12.4.2.3. Others
12.4.3. Biosynthetic
12.4.3.1. Ovine Collagen with Polyester
12.4.3.2. Others
12.5. Market Value Forecast, by Application , 2017–2031
12.5.1. Coronary Artery Bypass
12.5.2. Aneurysm
12.5.3. Vascular Occlusion
12.5.4. Critical Limb Ischemia
12.5.5. Renal Failure
12.5.6. Others
12.6. Market Value Forecast, by End-user, 2017–2031
12.6.1. Hospitals
12.6.2. Ambulatory Surgery Centers
12.6.3. Cardiac Catheterization Laboratories
12.6.4. Specialty Clinics
12.6.5. Others
12.7. Market Value Forecast, by Country, 2017–2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Size of Vascular Graft
12.8.3. By Source
12.8.4. By Application
12.8.5. By End-user
12.8.6. By Country
13. Europe Vascular Grafts Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Endovascular Stent Graft
13.2.2. Peripheral Vascular Graft
13.2.3. Hemodialysis Access Graft
13.2.4. Bypass Graft
13.2.5. Others
13.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
13.3.1. Large Size Vascular Graft
13.3.2. Small Size Vascular Graft
13.4. Market Value Forecast, by Source, 2017–2031
13.4.1. Synthetic
13.4.1.1. Polytetrafluethylene (PTFE)
13.4.1.2. Polyurethane (PU)
13.4.1.3. Dacron
13.4.1.4. Others
13.4.2. Biological
13.4.2.1. Bovine Vein
13.4.2.2. Saphenous Vein
13.4.2.3. Others
13.4.3. Biosynthetic
13.4.3.1. Ovine Collagen with Polyester
13.4.3.2. Others
13.5. Market Value Forecast, by Application, 2017–2031
13.5.1. Coronary Artery Bypass
13.5.2. Aneurysm
13.5.3. Vascular Occlusion
13.5.4. Critical Limb Ischemia
13.5.5. Renal Failure
13.5.6. Others
13.6. Market Value Forecast, by End-user, 2017–2031
13.6.1. Hospitals
13.6.2. Ambulatory Surgery Centers
13.6.3. Cardiac Catheterization Laboratories
13.6.4. Specialty Clinics
13.6.5. Others
13.7. Market Value Forecast, by Country/Sub-region, 2017–2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Size of Vascular Graft
13.8.3. By Source
13.8.4. By Application
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Vascular Grafts Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Endovascular Stent Graft
14.2.2. Peripheral Vascular Graft
14.2.3. Hemodialysis Access Graft
14.2.4. Bypass Graft
14.2.5. Others
14.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
14.3.1. Large Size Vascular Graft
14.3.2. Small Size Vascular Graft
14.4. Market Value Forecast, by Source, 2017–2031
14.4.1. Synthetic
14.4.1.1. Polytetrafluethylene (PTFE)
14.4.1.2. Polyurethane (PU)
14.4.1.3. Dacron
14.4.1.4. Others
14.4.2. Biological
14.4.2.1. Bovine Vein
14.4.2.2. Saphenous Vein
14.4.2.3. Others
14.4.3. Biosynthetic
14.4.3.1. Ovine Collagen with Polyester
14.4.3.2. Others
14.5. Market Value Forecast, by Application, 2017–2031
14.5.1. Coronary Artery Bypass
14.5.2. Aneurysm
14.5.3. Vascular Occlusion
14.5.4. Critical Limb Ischemia
14.5.5. Renal Failure
14.5.6. Others
14.6. Market Value Forecast, by End-user, 2017–2031
14.6.1. Hospitals
14.6.2. Ambulatory Surgery Centers
14.6.3. Cardiac Catheterization Laboratories
14.6.4. Specialty Clinics
14.6.5. Others
14.7. Market Value Forecast, by Country/Sub-region, 2017–2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Product
14.8.2. By Size of Vascular Graft
14.8.3. By Source
14.8.4. By Application
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Vascular Grafts Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Endovascular Stent Graft
15.2.2. Peripheral Vascular Graft
15.2.3. Hemodialysis Access Graft
15.2.4. Bypass Graft
15.2.5. Others
15.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
15.3.1. Large Size Vascular Graft
15.3.2. Small Size Vascular Graft
15.4. Market Value Forecast, by Source, 2017–2031
15.4.1. Synthetic
15.4.1.1. Polytetrafluethylene (PTFE)
15.4.1.2. Polyurethane (PU)
15.4.1.3. Dacron
15.4.1.4. Others
15.4.2. Biological
15.4.2.1. Bovine Vein
15.4.2.2. Saphenous Vein
15.4.2.3. Others
15.4.3. Biosynthetic
15.4.3.1. Ovine Collagen with Polyester
15.4.3.2. Others
15.5. Market Value Forecast, by Application , 2017–2031
15.5.1. Coronary Artery Bypass
15.5.2. Aneurysm
15.5.3. Vascular Occlusion
15.5.4. Critical Limb Ischemia
15.5.5. Renal Failure
15.5.6. Others
15.6. Market Value Forecast, by End-user, 2017–2031
15.6.1. Hospitals
15.6.2. Ambulatory Surgery Centers
15.6.3. Cardiac Catheterization Laboratories
15.6.4. Specialty Clinics
15.6.5. Others
15.7. Market Value Forecast, by Country/Sub-region, 2017–2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Product
15.8.2. By Size of Vascular Graft
15.8.3. By Source
15.8.4. By Application
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Vascular Grafts Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product, 2017–2031
16.2.1. Endovascular Stent Graft
16.2.2. Peripheral Vascular Graft
16.2.3. Hemodialysis Access Graft
16.2.4. Bypass Graft
16.2.5. Others
16.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
16.3.1. Large Size Vascular Graft
16.3.2. Small Size Vascular Graft
16.4. Market Value Forecast, by Source, 2017–2031
16.4.1. Synthetic
16.4.1.1. Polytetrafluethylene (PTFE)
16.4.1.2. Polyurethane (PU)
16.4.1.3. Dacron
16.4.1.4. Others
16.4.2. Biological
16.4.2.1. Bovine Vein
16.4.2.2. Saphenous Vein
16.4.2.3. Others
16.4.3. Biosynthetic
16.4.3.1. Ovine Collagen with Polyester
16.4.3.2. Others
16.5. Market Value Forecast, by Application, 2017–2031
16.5.1. Coronary Artery Bypass
16.5.2. Aneurysm
16.5.3. Vascular Occlusion
16.5.4. Critical Limb Ischemia
16.5.5. Renal Failure
16.5.6. Others
16.6. Market Value Forecast, by End-user, 2017–2031
16.6.1. Hospitals
16.6.2. Ambulatory Surgery Centers
16.6.3. Cardiac Catheterization Laboratories
16.6.4. Specialty Clinics
16.6.5. Others
16.7. Market Value Forecast, by Country/Sub-region, 2017–2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Product
16.8.2. By Size of Vascular Graft
16.8.3. By Source
16.8.4. By Application
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (by tier and size of companies)
17.2. Market Share Analysis, by Company, 2021
17.3. Company Profiles
17.3.1. B. Braun SE
17.3.1.1. Company Overview
17.3.1.2. Product Portfolio
17.3.1.3. SWOT Analysis
17.3.1.4. Strategic Overview
17.3.2. BD
17.3.2.1. Company Overview
17.3.2.2. Product Portfolio
17.3.2.3. SWOT Analysis
17.3.2.4. Strategic Overview
17.3.3. Cook Medical, Inc.
17.3.3.1. Company Overview
17.3.3.2. Product Portfolio
17.3.3.3. SWOT Analysis
17.3.3.4. Strategic Overview
17.3.4. CryoLife, Inc.
17.3.4.1. Company Overview
17.3.4.2. Product Portfolio
17.3.4.3. SWOT Analysis
17.3.4.4. Strategic Overview
17.3.5. Getinge AB
17.3.5.1. Company Overview
17.3.5.2. Product Portfolio
17.3.5.3. SWOT Analysis
17.3.5.4. Strategic Overview
17.3.6. Heart Medical
17.3.6.1. Company Overview
17.3.6.2. Product Portfolio
17.3.6.3. SWOT Analysis
17.3.6.4. Strategic Overview
17.3.7. JUNKEN MEDICAL Co., Ltd.
17.3.7.1. Company Overview
17.3.7.2. Product Portfolio
17.3.7.3. SWOT Analysis
17.3.7.4. Strategic Overview
17.3.8. LeMaitre Vascular, Inc.
17.3.8.1. Company Overview
17.3.8.2. Product Portfolio
17.3.8.3. SWOT Analysis
17.3.8.4. Strategic Overview
17.3.9. Medtronic
17.3.9.1. Company Overview
17.3.9.2. Product Portfolio
17.3.9.3. SWOT Analysis
17.3.9.4. Strategic Overview
17.3.10. Terumo Corporation
17.3.10.1. Company Overview
17.3.10.2. Product Portfolio
17.3.10.3. SWOT Analysis
17.3.10.4. Strategic Overview
17.3.11. Vascular Graft Solutions
17.3.11.1. Company Overview
17.3.11.2. Product Portfolio
17.3.11.3. SWOT Analysis
17.3.11.4. Strategic Overview
17.3.12. W. L. Gore & Associates, Inc.
17.3.12.1. Company Overview
17.3.12.2. Product Portfolio
17.3.12.3. SWOT Analysis
17.3.12.4. Strategic Overview
List of Tables
Table 01: Global Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 02: Global Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031
Table 03: Global Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic Source, 2017‒2031
Table 04: Global Vascular Graft Market Value (US$ Mn) Forecast, by Biological Source, 2017‒2031
Table 05: Global Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic Source, 2017‒2031
Table 06: Global Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017‒2031
Table 07: Global Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 08: Global Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 09: Global Vascular Graft Market Value (US$ Mn) Forecast, by Region, 2017‒2031
Table 10: North America Vascular Graft Market Value (US$ Mn) Forecast, by Country, 2017‒2031
Table 11: North America Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 12: North America Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031
Table 13: North America Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017‒2031
Table 14: North America Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017‒2031
Table 15: North America Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017‒2031
Table 16: North America Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017‒2031
Table 17: North America Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 18: North America Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 19: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031
Table 20: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 21: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031
Table 22: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017‒2031
Table 23: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017‒2031
Table 24: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017‒2031
Table 25: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017‒2031
Table 26: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 27: Europe Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 28: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031
Table 29: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 30: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031
Table 31: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017‒2031
Table 32: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017‒2031
Table 33: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017‒2031
Table 34: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017‒2031
Table 35: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 36: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 37: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031
Table 38: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 39: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031
Table 40: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017‒2031
Table 41: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017‒2031
Table 42: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic Source, 2017‒2031
List of Figures
Figure 01: Global Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031
Figure 02: Global Vascular Grafts Market Value Share, by Product, 2021
Figure 03: Global Vascular Grafts Market Value Share, by Size of Vascular Graft, 2021
Figure 04: Global Vascular Grafts Market Value Share, by Source, 2021
Figure 04: Global Vascular Grafts Market Value Share, by Application, 2021
Figure 04: Global Vascular Grafts Market Value Share, by End-user, 2021
Figure 05: Global Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
Figure 06: Global Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031
Figure 09: Global Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
Figure 10: Global Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031
Figure 11: Global Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
Figure 12: Global Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031
Figure 13: Global Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
Figure 14: Global Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031
Figure 15: Global Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
Figure 16: Global Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031
Figure 17: Global Vascular Grafts Market Value Share Analysis, by Region, 2021 and 2031
Figure 18: Global Vascular Grafts Market Attractiveness Analysis, by Region, 2022–2031
Figure 19: North America Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031
Figure 20: North America Vascular Grafts Market Value Share Analysis, by Country, 2021 and 2031
Figure 21: North America Vascular Grafts Market Attractiveness Analysis, by Country, 2022–2031
Figure 22: North America Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
Figure 23: North America Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031
Figure 24: North America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
Figure 25: North America Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031
Figure 26: North America Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
Figure 27: North America Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031
Figure 28: North America Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
Figure 29: North America Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031
Figure 30: North America Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
Figure 31: North America Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031
Figure 32: Europe Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031
Figure 33: Europe Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 34: Europe Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 35: Europe Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
Figure 36: Europe Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031
Figure 37: Europe Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
Figure 38: Europe Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031
Figure 39: Europe Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
Figure 40: Europe Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031
Figure 41: Europe Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
Figure 42: Europe Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031
Figure 43: Europe Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
Figure 44: Europe Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031
Figure 45: Asia Pacific Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031
Figure 46: Asia Pacific Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 47: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 48: Asia Pacific Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
Figure 49: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031
Figure 50: Asia Pacific Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
Figure 51: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031
Figure 52: Asia Pacific Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
Figure 53: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031
Figure 54: Asia Pacific Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
Figure 55: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031
Figure 56: Asia Pacific Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
Figure 57: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031
Figure 58: Latin America Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031
Figure 59: Latin America Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 60: Latin America Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 61: Latin America Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
Figure 62: Latin America Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031
Figure 63: Latin America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
Figure 64: Latin America Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031
Figure 65: Latin America Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
Figure 66: Latin America Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031
Figure 67: Latin America Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
Figure 68: Latin America Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031
Figure 69: Latin America Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
Figure 70: Latin America Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031
Figure 71: Middle East & Africa Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031
Figure 72: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 73: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 74: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
Figure 75: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031
Figure 76: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
Figure 77: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031
Figure 78: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
Figure 79: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031
Figure 80: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
Figure 81: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031
Figure 82: Middle East & Africa Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
Figure 83: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031
Figure 84: Company Share Analysis, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Vascular Grafts Market
